Review article · 2013 · Open access

Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells

Xiaohong Xu, Zhong Zhong

Acta Pharmacologica Sinica, 34(6), 755–764 · Published 20 May 2013 · DOI 10.1038/aps.2013.63

Open PDFView at the publisherCite this paper

In brief

“Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells” is a 2013 review article by Xiaohong Xu and Zhong Zhong, published in Acta Pharmacologica Sinica. OpenAlex counts 73 citations as of 21 November 2026, which puts it in the top 8% of works published in 2013 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Acta Pharmacologica Sinica.

Citations
73
Most cited in
2017 (11)
Field-weighted impact
0.67
References
104
Authors
2

Abstract

With the general decline of pharmaceutical research productivity, there are concerns that many components of the drug discovery process need to be redesigned and optimized. For example, the human immortalized cell lines or animal primary cells commonly used in traditional drug screening may not faithfully recapitulate the pathological mechanisms of human diseases, leading to biases in assays, targets, or compounds that do not effectively address disease mechanisms. Recent advances in stem cell research, especially in the development of induced pluripotent stem cell (iPSC) technology, provide a new paradigm for drug screening by permitting the use of human cells with the same genetic makeup as the patients without the typical quantity constraints associated with patient primary cells. In this article, we will review the progress made to date on cellular disease models using human stem cells, with a focus on patient-specific iPSCs for neurological diseases. We will discuss the key challenges and the factors that associated with the success of using stem cell models for drug discovery through examples from monogenic diseases, diseases with various known genetic components, and complex diseases caused by a combination of genetic, environmental and other factors.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Xu, X., & Zhong, Z. (2013). Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacologica Sinica, 34(6), 755–764. https://doi.org/10.1038/aps.2013.63

MLA 9

Xu, Xiaohong, and Zhong Zhong. “Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.” Acta Pharmacologica Sinica, vol. 34, no. 6, 2013, pp. 755–764. https://doi.org/10.1038/aps.2013.63.

Chicago

Xu, Xiaohong and Zhong Zhong. 2013. “Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.” Acta Pharmacologica Sinica 34 (6): 755–764. https://doi.org/10.1038/aps.2013.63.

Harvard

Xu, X. and Zhong, Z. (2013) ‘Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells’, Acta Pharmacologica Sinica, 34(6), pp. 755–764. doi:10.1038/aps.2013.63.

IEEE

X. Xu and Z. Zhong, “Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells,” Acta Pharmacologica Sinica, vol. 34, no. 6, pp. 755–764, 2013, doi: 10.1038/aps.2013.63.

BibTeX

@article{xu2013disease,
  title     = {{Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells}},
  author    = {Xu, Xiaohong and Zhong, Zhong},
  journal   = {Acta Pharmacologica Sinica},
  year      = {2013},
  volume    = {34},
  number    = {6},
  pages     = {755--764},
  doi       = {10.1038/aps.2013.63},
  url       = {https://doi.org/10.1038/aps.2013.63}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20171111
201888
201988
202055
202133
202255
202322
202422
202522
202622

Its field-weighted citation impact is 0.67: it has been cited 0.67 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • neurological disorders
  • disease modeling
  • drug screening
  • patient-derived iPSCs
  • drug discovery
  • monogenic disorders
  • complex genetic disorders

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Xu, X., & Zhong, Z. (2013). Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacologica Sinica, 34(6), 755–764. https://doi.org/10.1038/aps.2013.63

How many times has this paper been cited?

73 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Pharmacologica Sinica: sign in and open the PDF from this page.

Who wrote this paper?

Xiaohong Xu, Zhong Zhong.

What is the DOI of this paper?

10.1038/aps.2013.63, permanently at https://doi.org/10.1038/aps.2013.63. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.